Newsletter
Sign up for our Newsletter to receive content and news about Medical Cannabis and stay informed about our promotions.
EXCLUSIVE THRONUS TECHNOLOGY
Why is Thronus the market leader?
Thronus technology, a patent pending discovery, uses the PoweeNano™ Technology formulation. Our exclusive Thronus technology can increase the absorption of cannabinoids in the body by up to 10 times more than oils.
In addition to our innovative technology, we are engaged in clinical research and develop formulations of different efficacy levels for physical and psychological treatment, with organic products manufactured in Canada.
For better understanding, here are some technical terms relevant to our biocompatibility:
Bioavailability: the extent to which the characteristics administered are biologically incorporated for use in our biological system for a specific purpose.
In the case of CBD, it is the endocannabinoid system.
WHEN INGESTING A CBD PRODUCT, HOW MUCH IS ACTUALLY ABSORBED?
We know that CBD oils traditionally have low absorption rates because they are barely digested in the gastrointestinal system. In fact, traditional CBD oils are composed of molecules that are too large, creating difficulties to overcome the mucus barrier.
Studies show that the bioavailability of traditional CBD is around 6-9%. This is a very low figure for most drugs, requiring very large doses to achieve therapeutic targets.
So, why take a solution that contains oil and wastes the biocompatibility of Cannabinoids? Studies show that particles developed through PoweeNano™ technology are nano-sized lipophobic carriers that dispose immediately in water, penetrate mucus, and deliver to receptor cells in our tissues.
This means that with only one dose, with our customized results, we obtain a 90% success rate. → EFFICACY!
BISALIV IS THE EVOLUTION IN MEDICINAL CANNABIS TREATMENT
 |  |
|
|---|---|---|
| Better cost-benefit ratio | X |  |
| Versatile use (can be added to water, juice, tea) | X | |
| Rapid onset of action | X | |
| Greater absorption | X | |
| Lower dose | X | |
| Economy | X | |
| Not affected by diet | X | |
| Easy dosage and titration | X | |
| Longer bottle durability | X | |
| High efficiency in sublingual use | X | |
| Reduces risk of drug interactions | X | |
| Reduces risk of side effects | X | |
| Nanomedicine | X | |
| Better bioavailability | X | |
| Reduces hepatic and intestinal metabolism | X | |
| Increases lymphatic absorption | X | |
| Water-soluble | X | |
| Rapid penetration through intestinal cell membrane | X | |
Yield Comparison
1 bottle of Bisaliv
3 bottles of conventional oil
